Neda A. Sharifi

Senior Counsel

Back

Neda A. Sharifi

Senior Counsel

Jacksonville 904.359.8719

Sectors

Practice Areas

Education

  • Florida Coastal School of Law (J.D., magna cum laude)
  • Johns Hopkins School of Medicine (Ph.D.)
    • Human Genetics and Molecular Biology
  • University of Maryland (B.S.)
    • Physiology and Neurobiology

Admissions

  • Florida
  • United States Patent and Trademark Office

Neda A. Sharifi, Ph.D. is a senior counsel and business lawyer with Foley & Lardner LLP. Her practice is focused on corporate and securities laws matters, including mergers and acquisitions and securities law compliance counseling. She also handles a wide variety of commercial contracts, including technology related agreements. Neda is a member of the firm’s Transactional & Securities and Finance & Financial Institutions Practices.

Neda has advised inventors on protection and management of intellectual property rights. She has prosecuted numerous domestic and foreign patent applications. Her experience has also included providing scientific advice to international and national corporations.

Prior to joining Foley, Neda served as a registered patent agent to a large corporate law firm.

Awards and Recognition

  • Who’s Who in the World
  • Who’s Who in America
  • Who’s Who in Science and Engineering

Publications and Presentations

  • Co-author, “Expansive Interpretation of Caremark Creates Challenges for Private Company Boards,” Westlaw Journal Corporate Officers and Directors Liability, August 16, 2019
  • “VC Funds Face Risk Appointing Representatives To Board,” Corporate Board Member, April 12, 2018
  • “Delaware Court Invalidates Supermajority Bylaw to Remove Directors Without Cause,” Westlaw Journal: Expert Analysis, March 20, 2017
  • “CEOs Provide Common Sense Corporate Governance Principles,” Bloomberg BNA: Corporate Law & Accountability Report, October 18, 2016
  • “Bylaw Wars: Boards Awaken,” The Corporate Board, March/April 2016
  • “Delaware Curbs Frivolous Merger Suits with More Critical Review of Disclosure-Only Pacts,” Westlaw Journal: Delaware Corporate, October 12, 2015
  • “Delaware Court Delays C&J Energy Merger for Flawed Sale Process,” Westlaw Journal: Corporate Officers & Directors Liability, December 15, 2014

Neda is also a regular speaker, having presented at several national and international conferences regarding research findings in gene regulation.

Languages

  • Farsi (Fluent)
28 July 2022 Deals and Wins

Foley Represents Mirantis in Acquisition of amazee.io

Foley & Lardner LLP represented Mirantis, an open source cloud computing software and services company, in its acquisition of amazee.io, a global web application delivery company for Kubernetes.
14 May 2021 Press Releases

Foley Advises Continental Properties on Closing of Multifamily Real Estate Income Fund

Foley & Lardner LLP assisted Continental Properties Company, Inc., a privately held, national multifamily and commercial real estate developer and operator, on its closing of Continental Properties Real Estate Income Fund II, L.P.
02 July 2020 Press Releases

Foley Represents Innovative Industrial Properties in $258.7 Million Common Stock Offering

Foley & Lardner advised Innovative Industrial Properties, Inc., a pioneering real estate investment trust focused on the regulated medical-use cannabis industry, in a public offering of its common stock raising gross offering proceeds of approximately $258.7 million.
28 January 2020 Press Releases

Foley Represents Innovative Industrial Properties in $250 Million Cannabis REIT Offering

Foley & Lardner LLP represented Innovative Industrial Properties, Inc. in connection with its recent follow-on public offering of common stock, raising gross proceeds of approximately $250.0 million.
13 January 2020 Blogs

Health Care Provider Director and Officer Liability: Important Takeaways from Clovis and Marchand

Health care provider boards of directors have been put on notice—given these two recent Delaware court decisions - Clovis and Marchand—that courts may be willing to significantly extend a corporate board’s Caremark duty to monitor.
17 December 2019 Article

INSIGHT: Delaware Cases Portent Key Developments in Board’s Caremark Duty

Corporate directors face an increased risk of shareholders’ lawsuits whenever the corporation suffers damage from a violation of law or other material risk area, in light of two recent Delaware cases.
View All Insights
View Newsroom